Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules
Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca2+)-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pc...
Gespeichert in:
Veröffentlicht in: | Biochimica et biophysica acta. Molecular basis of disease 2021-03, Vol.1867 (3), p.166040-166040, Article 166040 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 166040 |
---|---|
container_issue | 3 |
container_start_page | 166040 |
container_title | Biochimica et biophysica acta. Molecular basis of disease |
container_volume | 1867 |
creator | Aslam, Akhmed Ahmad, Jawwad Baghdadi, Mohammed A. Idris, Shakir Almaimani, Riyad Alsaegh, Aiman Alhadrami, Mai Refaat, Bassem |
description | Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca2+)-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pcal), ± 5-FU in relation to chemoprevention and Ca2+-mediated apoptosis in vivo and in vitro.
Seventy male mice were distributed to: negative controls, positive controls (PC), VD, Pcal, 5-FU, VD + 5-FU and Pcal+5-FU groups. All groups, except negative, received two consecutive azoxymethane (AOM)-injections (10 mg/Kg/week) for CRC induction. VD3 (1000 IU/kg; three times/week) and Pcal (1.25 μg/kg; three times/week) injections started week-16 post-AOM and for 10 weeks. Three successive 5-FU cycles began at week-21 (50 mg/Kg/week). Similar protocols with VD3, Pcal and/or 5-FU were applied in the HT29 colon cancer cells.
The PC group had abundant malignant tumours, markedly elevated proliferation markers (survivin/CCND1) and declines in cyclin-dependent kinase-inhibitor-1A, pro-apoptotic molecules (p53/BAX/cytochrome_C/caspase-3), tissue Ca2+ concentrations and Ca2+-dependent proteins (CaSR/CAM/CAMKIIA). All monotherapies equally reduced tumour numbers and proliferation markers whilst promoting the anti-tumorigenic molecules. VD and/or 5-FU, but not Pcal monotherapy, enhanced Ca2+ levels and Ca2+-related molecules (CaSR/CAM/CAMKIIA/BAX/cytochrome_C) in vivo and in vitro. However, VD + 5-FU co-therapy showed the lowest tumour numbers, the highest cell numbers in sub-G1 phase of cell cycle, alongside the most effective modulations of oncogenes, tumour suppressors and Ca2+-related molecules at the gene and protein levels in vivo and in vitro.
VD3 was superior than Paricalcitol in potentiating 5-FU cytotoxicity, possibly by upregulating several Ca2+-related molecules involved in tumour suppression.
[Display omitted]
•Calcium signalling molecules are pathologically altered in colon carcinogenesis.•VD and Pcal monotherapies equally resulted in moderate chemoprevention against CRC.•VD/5-FU co-therapy showed the highest anti-cancer effects in vivo and in vitro.•Improvements of VD/5-FU co-therapy could be related to Ca2+-induced apoptosis. |
doi_str_mv | 10.1016/j.bbadis.2020.166040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2471457995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0925443920303884</els_id><sourcerecordid>2471457995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-bee3e44387bb424ed31dd6bbdbef8c1c6c1c8f5c59a7e3e496787885327a11e73</originalsourceid><addsrcrecordid>eNp9kc2qFDEQhYMoOF59AxdZurg9N-m_dLsQZPy5wgU3V3AXqtPVMzWkkzFJj_hOPqRp27WBEKh8dQ5Vh7HXUuylkO3deT8MMFLcl6LMpbYVtXjCdrJTfVG24vtTthN92RR1XfXP2YsYzyKfVokd-3044ewvAa_oEl2R4zShSZH7iV8pwUyOf6g4uJFTroID648L3vILBDJgDSVvb3mmjJ8HcpDIO_6T0ok3xWQXH_wSwJDlcARyMWXO-pAtwHIDzmB4yx9PyIO3uJr-1VxmHumYvSy5I5_zl1ksxpfs2QQ24qt_7w379unj4-G-ePj6-cvh_UNhqq5JxYBYYZ61U8NQlzWOlRzHdhjGAafOSNPm202NaXpQK9m3qlNd11SlAilRVTfszaZ7Cf7HgjHpmaJBa8GhX6IuayXrRvV9k9F6Q03wMQac9CXQDOGXlkKv4eiz3sLRazh6Cye3vdvaMI9xJQw6GsK8jZHW3ejR0_8F_gAdE54n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471457995</pqid></control><display><type>article</type><title>Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules</title><source>Elsevier ScienceDirect Journals</source><source>EZB Electronic Journals Library</source><creator>Aslam, Akhmed ; Ahmad, Jawwad ; Baghdadi, Mohammed A. ; Idris, Shakir ; Almaimani, Riyad ; Alsaegh, Aiman ; Alhadrami, Mai ; Refaat, Bassem</creator><creatorcontrib>Aslam, Akhmed ; Ahmad, Jawwad ; Baghdadi, Mohammed A. ; Idris, Shakir ; Almaimani, Riyad ; Alsaegh, Aiman ; Alhadrami, Mai ; Refaat, Bassem</creatorcontrib><description>Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca2+)-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pcal), ± 5-FU in relation to chemoprevention and Ca2+-mediated apoptosis in vivo and in vitro.
Seventy male mice were distributed to: negative controls, positive controls (PC), VD, Pcal, 5-FU, VD + 5-FU and Pcal+5-FU groups. All groups, except negative, received two consecutive azoxymethane (AOM)-injections (10 mg/Kg/week) for CRC induction. VD3 (1000 IU/kg; three times/week) and Pcal (1.25 μg/kg; three times/week) injections started week-16 post-AOM and for 10 weeks. Three successive 5-FU cycles began at week-21 (50 mg/Kg/week). Similar protocols with VD3, Pcal and/or 5-FU were applied in the HT29 colon cancer cells.
The PC group had abundant malignant tumours, markedly elevated proliferation markers (survivin/CCND1) and declines in cyclin-dependent kinase-inhibitor-1A, pro-apoptotic molecules (p53/BAX/cytochrome_C/caspase-3), tissue Ca2+ concentrations and Ca2+-dependent proteins (CaSR/CAM/CAMKIIA). All monotherapies equally reduced tumour numbers and proliferation markers whilst promoting the anti-tumorigenic molecules. VD and/or 5-FU, but not Pcal monotherapy, enhanced Ca2+ levels and Ca2+-related molecules (CaSR/CAM/CAMKIIA/BAX/cytochrome_C) in vivo and in vitro. However, VD + 5-FU co-therapy showed the lowest tumour numbers, the highest cell numbers in sub-G1 phase of cell cycle, alongside the most effective modulations of oncogenes, tumour suppressors and Ca2+-related molecules at the gene and protein levels in vivo and in vitro.
VD3 was superior than Paricalcitol in potentiating 5-FU cytotoxicity, possibly by upregulating several Ca2+-related molecules involved in tumour suppression.
[Display omitted]
•Calcium signalling molecules are pathologically altered in colon carcinogenesis.•VD and Pcal monotherapies equally resulted in moderate chemoprevention against CRC.•VD/5-FU co-therapy showed the highest anti-cancer effects in vivo and in vitro.•Improvements of VD/5-FU co-therapy could be related to Ca2+-induced apoptosis.</description><identifier>ISSN: 0925-4439</identifier><identifier>EISSN: 1879-260X</identifier><identifier>DOI: 10.1016/j.bbadis.2020.166040</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Bcl-2-associated X protein ; Calcium ; Calmodulin ; Calmodulin-dependent kinase II ; Cytochrome C ; Vitamin D receptor</subject><ispartof>Biochimica et biophysica acta. Molecular basis of disease, 2021-03, Vol.1867 (3), p.166040-166040, Article 166040</ispartof><rights>2020 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-bee3e44387bb424ed31dd6bbdbef8c1c6c1c8f5c59a7e3e496787885327a11e73</citedby><cites>FETCH-LOGICAL-c385t-bee3e44387bb424ed31dd6bbdbef8c1c6c1c8f5c59a7e3e496787885327a11e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0925443920303884$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Aslam, Akhmed</creatorcontrib><creatorcontrib>Ahmad, Jawwad</creatorcontrib><creatorcontrib>Baghdadi, Mohammed A.</creatorcontrib><creatorcontrib>Idris, Shakir</creatorcontrib><creatorcontrib>Almaimani, Riyad</creatorcontrib><creatorcontrib>Alsaegh, Aiman</creatorcontrib><creatorcontrib>Alhadrami, Mai</creatorcontrib><creatorcontrib>Refaat, Bassem</creatorcontrib><title>Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules</title><title>Biochimica et biophysica acta. Molecular basis of disease</title><description>Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca2+)-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pcal), ± 5-FU in relation to chemoprevention and Ca2+-mediated apoptosis in vivo and in vitro.
Seventy male mice were distributed to: negative controls, positive controls (PC), VD, Pcal, 5-FU, VD + 5-FU and Pcal+5-FU groups. All groups, except negative, received two consecutive azoxymethane (AOM)-injections (10 mg/Kg/week) for CRC induction. VD3 (1000 IU/kg; three times/week) and Pcal (1.25 μg/kg; three times/week) injections started week-16 post-AOM and for 10 weeks. Three successive 5-FU cycles began at week-21 (50 mg/Kg/week). Similar protocols with VD3, Pcal and/or 5-FU were applied in the HT29 colon cancer cells.
The PC group had abundant malignant tumours, markedly elevated proliferation markers (survivin/CCND1) and declines in cyclin-dependent kinase-inhibitor-1A, pro-apoptotic molecules (p53/BAX/cytochrome_C/caspase-3), tissue Ca2+ concentrations and Ca2+-dependent proteins (CaSR/CAM/CAMKIIA). All monotherapies equally reduced tumour numbers and proliferation markers whilst promoting the anti-tumorigenic molecules. VD and/or 5-FU, but not Pcal monotherapy, enhanced Ca2+ levels and Ca2+-related molecules (CaSR/CAM/CAMKIIA/BAX/cytochrome_C) in vivo and in vitro. However, VD + 5-FU co-therapy showed the lowest tumour numbers, the highest cell numbers in sub-G1 phase of cell cycle, alongside the most effective modulations of oncogenes, tumour suppressors and Ca2+-related molecules at the gene and protein levels in vivo and in vitro.
VD3 was superior than Paricalcitol in potentiating 5-FU cytotoxicity, possibly by upregulating several Ca2+-related molecules involved in tumour suppression.
[Display omitted]
•Calcium signalling molecules are pathologically altered in colon carcinogenesis.•VD and Pcal monotherapies equally resulted in moderate chemoprevention against CRC.•VD/5-FU co-therapy showed the highest anti-cancer effects in vivo and in vitro.•Improvements of VD/5-FU co-therapy could be related to Ca2+-induced apoptosis.</description><subject>Bcl-2-associated X protein</subject><subject>Calcium</subject><subject>Calmodulin</subject><subject>Calmodulin-dependent kinase II</subject><subject>Cytochrome C</subject><subject>Vitamin D receptor</subject><issn>0925-4439</issn><issn>1879-260X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc2qFDEQhYMoOF59AxdZurg9N-m_dLsQZPy5wgU3V3AXqtPVMzWkkzFJj_hOPqRp27WBEKh8dQ5Vh7HXUuylkO3deT8MMFLcl6LMpbYVtXjCdrJTfVG24vtTthN92RR1XfXP2YsYzyKfVokd-3044ewvAa_oEl2R4zShSZH7iV8pwUyOf6g4uJFTroID648L3vILBDJgDSVvb3mmjJ8HcpDIO_6T0ok3xWQXH_wSwJDlcARyMWXO-pAtwHIDzmB4yx9PyIO3uJr-1VxmHumYvSy5I5_zl1ksxpfs2QQ24qt_7w379unj4-G-ePj6-cvh_UNhqq5JxYBYYZ61U8NQlzWOlRzHdhjGAafOSNPm202NaXpQK9m3qlNd11SlAilRVTfszaZ7Cf7HgjHpmaJBa8GhX6IuayXrRvV9k9F6Q03wMQac9CXQDOGXlkKv4eiz3sLRazh6Cye3vdvaMI9xJQw6GsK8jZHW3ejR0_8F_gAdE54n</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Aslam, Akhmed</creator><creator>Ahmad, Jawwad</creator><creator>Baghdadi, Mohammed A.</creator><creator>Idris, Shakir</creator><creator>Almaimani, Riyad</creator><creator>Alsaegh, Aiman</creator><creator>Alhadrami, Mai</creator><creator>Refaat, Bassem</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210301</creationdate><title>Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules</title><author>Aslam, Akhmed ; Ahmad, Jawwad ; Baghdadi, Mohammed A. ; Idris, Shakir ; Almaimani, Riyad ; Alsaegh, Aiman ; Alhadrami, Mai ; Refaat, Bassem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-bee3e44387bb424ed31dd6bbdbef8c1c6c1c8f5c59a7e3e496787885327a11e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bcl-2-associated X protein</topic><topic>Calcium</topic><topic>Calmodulin</topic><topic>Calmodulin-dependent kinase II</topic><topic>Cytochrome C</topic><topic>Vitamin D receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aslam, Akhmed</creatorcontrib><creatorcontrib>Ahmad, Jawwad</creatorcontrib><creatorcontrib>Baghdadi, Mohammed A.</creatorcontrib><creatorcontrib>Idris, Shakir</creatorcontrib><creatorcontrib>Almaimani, Riyad</creatorcontrib><creatorcontrib>Alsaegh, Aiman</creatorcontrib><creatorcontrib>Alhadrami, Mai</creatorcontrib><creatorcontrib>Refaat, Bassem</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aslam, Akhmed</au><au>Ahmad, Jawwad</au><au>Baghdadi, Mohammed A.</au><au>Idris, Shakir</au><au>Almaimani, Riyad</au><au>Alsaegh, Aiman</au><au>Alhadrami, Mai</au><au>Refaat, Bassem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules</atitle><jtitle>Biochimica et biophysica acta. Molecular basis of disease</jtitle><date>2021-03-01</date><risdate>2021</risdate><volume>1867</volume><issue>3</issue><spage>166040</spage><epage>166040</epage><pages>166040-166040</pages><artnum>166040</artnum><issn>0925-4439</issn><eissn>1879-260X</eissn><abstract>Although vitamin D (VD) is chemoprotective and enhances 5-fluorouracil (5-FU) cytotoxicity against colorectal cancer (CRC), little is known about its potential calcium (Ca2+)-mediated anti-tumorigenic actions. Therefore, this study compared between VD and its non-calcaemic analogue, Paricalcitol (Pcal), ± 5-FU in relation to chemoprevention and Ca2+-mediated apoptosis in vivo and in vitro.
Seventy male mice were distributed to: negative controls, positive controls (PC), VD, Pcal, 5-FU, VD + 5-FU and Pcal+5-FU groups. All groups, except negative, received two consecutive azoxymethane (AOM)-injections (10 mg/Kg/week) for CRC induction. VD3 (1000 IU/kg; three times/week) and Pcal (1.25 μg/kg; three times/week) injections started week-16 post-AOM and for 10 weeks. Three successive 5-FU cycles began at week-21 (50 mg/Kg/week). Similar protocols with VD3, Pcal and/or 5-FU were applied in the HT29 colon cancer cells.
The PC group had abundant malignant tumours, markedly elevated proliferation markers (survivin/CCND1) and declines in cyclin-dependent kinase-inhibitor-1A, pro-apoptotic molecules (p53/BAX/cytochrome_C/caspase-3), tissue Ca2+ concentrations and Ca2+-dependent proteins (CaSR/CAM/CAMKIIA). All monotherapies equally reduced tumour numbers and proliferation markers whilst promoting the anti-tumorigenic molecules. VD and/or 5-FU, but not Pcal monotherapy, enhanced Ca2+ levels and Ca2+-related molecules (CaSR/CAM/CAMKIIA/BAX/cytochrome_C) in vivo and in vitro. However, VD + 5-FU co-therapy showed the lowest tumour numbers, the highest cell numbers in sub-G1 phase of cell cycle, alongside the most effective modulations of oncogenes, tumour suppressors and Ca2+-related molecules at the gene and protein levels in vivo and in vitro.
VD3 was superior than Paricalcitol in potentiating 5-FU cytotoxicity, possibly by upregulating several Ca2+-related molecules involved in tumour suppression.
[Display omitted]
•Calcium signalling molecules are pathologically altered in colon carcinogenesis.•VD and Pcal monotherapies equally resulted in moderate chemoprevention against CRC.•VD/5-FU co-therapy showed the highest anti-cancer effects in vivo and in vitro.•Improvements of VD/5-FU co-therapy could be related to Ca2+-induced apoptosis.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.bbadis.2020.166040</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-4439 |
ispartof | Biochimica et biophysica acta. Molecular basis of disease, 2021-03, Vol.1867 (3), p.166040-166040, Article 166040 |
issn | 0925-4439 1879-260X |
language | eng |
recordid | cdi_proquest_miscellaneous_2471457995 |
source | Elsevier ScienceDirect Journals; EZB Electronic Journals Library |
subjects | Bcl-2-associated X protein Calcium Calmodulin Calmodulin-dependent kinase II Cytochrome C Vitamin D receptor |
title | Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T16%3A05%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemopreventive%20effects%20of%20vitamin%20D3%20and%20its%20analogue,%20paricalcitol,%20in%20combination%20with%205-fluorouracil%20against%20colorectal%20cancer:%20The%20role%20of%20calcium%20signalling%20molecules&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Molecular%20basis%20of%20disease&rft.au=Aslam,%20Akhmed&rft.date=2021-03-01&rft.volume=1867&rft.issue=3&rft.spage=166040&rft.epage=166040&rft.pages=166040-166040&rft.artnum=166040&rft.issn=0925-4439&rft.eissn=1879-260X&rft_id=info:doi/10.1016/j.bbadis.2020.166040&rft_dat=%3Cproquest_cross%3E2471457995%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471457995&rft_id=info:pmid/&rft_els_id=S0925443920303884&rfr_iscdi=true |